1Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
2Department of Anesthesiology and Pain Medicine, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea
3Institute of New Frontier Research Team, Hallym University, Chuncheon, Korea
4Department of Anesthesiology and Pain Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
© 2024 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: MSB, JHK. Data curation: DS, SSK, YY, JHK. Formal analysis: DS, SSK, YY, JHK. Methodology: MSB, JHK, YSK. Project administration: JHK. Visualization: JHK, YSK. Writing–original draft: JHK, MSB. Writing–review & editing: MSB, JHK, YSK.
ACKNOWLEDGMENTS
None.
Values are presented as median (interquartile range) or number (%).
SIRS: systemic inflammatory response syndrome; SOFA: Sequential Organ Failure Assessment; APACHE: Acute Physiology And Chronic Health Evaluation; COVID-19: coronavirus disease 2019; ICU: intensive care unit; MV: mechanical ventilation.
Variable | 30-Day survivor (n=8,217) | 30-Day non-survivor (n=1,546) | P-value |
---|---|---|---|
Age (yr) | 74 (62–82) | 78 (67–84) | <0.001 |
Male | 4,711 (57.3) | 972 (62.9) | <0.001 |
Body mass index (kg/m2) | 22.0 (19.5–24.6) | 20.8 (18.5–23.9) | <0.001 |
SIRS | 2 (1–3) | 2 (2–3) | <0.001 |
Quick SOFA score | 1 (1–2) | 2 (1–2) | <0.001 |
SOFA score | 5 (3–7) | 7 (4–9) | <0.001 |
APACHE II score | 16 (12–21) | 21 (16–27) | <0.001 |
Septic shock | 1,564 (19.0) | 423 (27.4) | <0.001 |
Charlson comorbidity index | 5 (4–7) | 6 (4–7) | <0.001 |
Comorbidity | |||
Hypertension | 4,983 (60.6) | 917 (59.3) | 0.341 |
Diabetes | 3,426 (41.7) | 585 (37.8) | 0.005 |
Cardiac disease | 2,774 (33.8) | 536 (34.7) | 0.506 |
Chronic lung disease | 1,769 (21.5) | 320 (20.7) | 0.486 |
Chronic renal disease | 1,554 (18.9) | 289 (18.7) | 0.868 |
Chronic liver disease | 1,226 (14.9) | 213 (13.8) | 0.261 |
Cerebrovascular disease | 2,741 (33.4) | 476 (30.8) | 0.052 |
Solid cancer | 1,653 (20.1) | 417 (27.0) | <0.001 |
Hematologic malignancy | 99 (1.2) | 29 (1.9) | 0.045 |
COVID-19 | 151 (1.8) | 44 (2.8) | 0.012 |
Vital sign | |||
Systolic blood pressure (mm Hg) | 122 (105–142) | 115 (98–136) | <0.001 |
Diastolic blood pressure (mm Hg) | 72 (61–85) | 69 (58–81) | <0.001 |
Respiratory rate (/min) | 20 (17–24) | 21 (17–25) | <0.001 |
Heart rate (/min) | 94 (80–109) | 100 (85–115) | <0.001 |
Body temperature (ºC) | 36.6 (36.2–37.2) | 36.4 (36.0–36.9) | <0.001 |
Glasgow coma scale | 14 (9–15) | 10 (5–14) | <0.001 |
Laboratory data | |||
White blood cell count (´103/L) | 11.5 (8.0–16.1) | 12.0 (8.0–16.9) | 0.005 |
Lymphocyte cell count (´103/L) | 1.0 (0.6–1.7)) | 0.9 (0.5–1.7 | 0.088 |
Hemoglobin | 11.7 (9.9–13.5) | 11.0 (9.1–13.0) | <0.001 |
Platelet count (´103/L) | 204 (140–278) | 193 (118–265) | <0.001 |
Albumin (g/dl) | 3.5 (3.0–3.9) | 3.1 (2.6–3.6) | <0.001 |
Cholesterol (g/dl) | 129 (100–162) | 114 (87–147) | <0.001 |
Creatinine (mg/dl) | 1.2 (0.8–2.0) | 1.4 (0.9–2.3) | 0.055 |
C-reactive protein (mg/dl) | 59.5 (10.9–153.2) | 86.3 (24.2–178.7) | <0.001 |
Procalcitonin (mmol/L) | 0.6 (0.1–4.9) | 0.9 (0.2–5.3) | 0.835 |
Lactic acid (mmol/L) | 2.0 (1.2–3.8) | 2.9 (1.6–6.2) | <0.001 |
Mechanical ventilation | 1,643 (20.0) | 602 (38.9) | <0.001 |
Renal replacement therapy | 724 (8.8) | 298 (19.3) | <0.001 |
Vasopressor use | 3,458 (42.1) | 967 (62.5) | <0.001 |
Corticosteroid use | 1,083 (13.2) | 344 (22.3) | <0.001 |
Transfusion | 1,341 (16.3) | 388 (25.1) | <0.001 |
Length of stay (day) | 15 (10–25) | 11 (7–17) | <0.001 |
ICU stay (day) | 5 (3–10) | 8 (5–14) | 0.002 |
Duration of MV (day) | 0 (0–2) | 5 (0–10) | <0.001 |
Variable | Total | 30-Day survivor | 30-Day non-survivor | P-value |
---|---|---|---|---|
Overall patients | (n=9,763) | (n=8,217) | (n=1,546) | |
CONUT score | 5 (3–7) | 5 (3–7) | 7 (4–9) | <0.001 |
CONUT category | <0.001 | |||
Absent (0–1) | 1,235 (12.6) | 1,108 (13.5) | 127 (8.2) | |
Mild (2–4) | 3,112 (31.9) | 2,775 (33.8) | 337 (21.8) | |
Moderate (5–8) | 3,788 (38.8) | 3,181 (38.7) | 607 (39.3) | |
Severe (9–12) | 1,628 (16.7) | 1,153 (14.0) | 475 (30.7) | |
PNI score | 39.6 (33.8–46.4) | 40.2 (34.5–46.8) | 35.9 (30.1–43.5) | <0.001 |
PNI category | <0.001 | |||
Absent (>38) | 5,580 (57.2) | 4,942 (60.1) | 638 (41.3) | |
Moderate (35–38) | 1,253 (12.8) | 1,064 (12.9) | 189 (12.2) | |
Severe (<35) | 2,930 (30.0) | 2,211 (26.9) | 719 (46.5) | |
Mechanically ventilated patients | (n=2245) | (n=1,643) | (n=602) | |
CONUT score | 4 (2–7) | 3 (1–6) | 5 (2–8) | <0.001 |
CONUT category | <0.001 | |||
Absent (0–1) | 529 (23.6) | 437 (26.6) | 92 (15.3) | |
Mild (2–4) | 732 (32.6) | 566 (34.4) | 166 (27.6) | |
Moderate (5–8) | 646 (28.8) | 447 (27.2) | 199 (33.1) | |
Severe (9–12) | 338 (15.1) | 193 (11.7) | 145 (24.1) | |
PNI score | 43.5 (35.4–54.6) | 44.2 (36.6–55.2) | 40.8 (31.9–52.7) | <0.001 |
PNI category | <0.001 | |||
Absent (>38) | 1,485 (66.1) | 1,150 (70.0) | 335 (55.6) | |
Moderate (35–38) | 216 (9.6) | 154 (9.4) | 62 (10.3) | |
Severe (<35) | 544 (24.2) | 339 (20.6) | 205 (34.1) |
Variable | Univariate analysis HR (95% CI) | P-value | Multivariable analysis HR (95% CI) | P-value |
---|---|---|---|---|
Overall patients | ||||
CONUT category | ||||
Absent (0–1) | 1.0 (Reference) | 1.0 (Reference) | ||
Mild (2–4) | 1.06 (0.86–1.30) | 0.588 | 1.10 (0.90–1.36) | 0.355 |
Moderate (5–8) | 1.61 (1.33–1.94) | <0.001 | 1.52 (1.24–1.87) | <0.001 |
Severe (9–12) | 3.17 (2.61–3.86) | <0.001 | 2.42 (1.95–3.02) | <0.001 |
CONUT per 1-point increase | 1.15 (1.13–1.17) | <0.001 | 1.10 (1.08–1.12) | <0.001 |
PNI category | ||||
Absent (>38) | 1.0 (Reference) | 1.0 (Reference) | ||
Moderate (35-38) | 1.34 (1.14–1.58) | <0.001 | 1.29 (1.09–1.53) | 0.003 |
Severe (<35) | 2.31 (2.08–2.57) | <0.001 | 1.88 (1.67–2.12) | <0.001 |
PNI per 1-point increase | 0.97 (0.97–0.98) | <0.001 | 0.98 (0.98–0.99) | <0.001 |
Mechanically ventilated patients | ||||
CONUT category | ||||
Absent (0–1) | 1.0 (Reference) | 1.0 (Reference) | ||
Mild (2–4) | 1.34 (1.04–1.73) | 0.025 | 1.23 (0.94–1.60) | 0.126 |
Moderate (5–8) | 1.92 (1.50–2.46) | <0.001 | 1.61 (1.23–2.11) | 0.001 |
Severe (9–12) | 2.87 (2.21–3.72) | <0.001 | 2.04 (1.50–2.76) | <0.001 |
CONUT per 1-point increase | 1.11 (1.08–1.13) | <0.001 | 1.07 (1.04–1.10) | <0.001 |
PNI category | ||||
Absent (>38) | 1.0 (Reference) | 1.0 (Reference) | ||
Moderate (35-38) | 1.32 (1.01–1.74) | 0.042 | 1.37 (1.04–1.81) | 0.027 |
Severe (<35) | 1.81 (1.52–2.15) | <0.001 | 1.47 (1.19–1.81) | <0.001 |
PNI per 1-point increase | 0.99 (0.98–0.99) | <0.001 | 0.99 (0.99–1.00) | 0.023 |
Values are presented as median (interquartile range) or number (%). SIRS: systemic inflammatory response syndrome; SOFA: Sequential Organ Failure Assessment; APACHE: Acute Physiology And Chronic Health Evaluation; COVID-19: coronavirus disease 2019; ICU: intensive care unit; MV: mechanical ventilation.
Values are presented as median (interquartile range) or number (%). CONUT: Controlling Nutritional Status; PNI: prognostic nutritional index.
HR: hazard ratio; CI: confidence interval; CONUT: Controlling Nutritional Status; PNI: prognostic nutritional index.